Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 207 clinical trials
featured
A Phase I/IIa, Randomized, Double-Blind, Placebo-Controlled, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Unilateral Intratympanic PIPE-505 in Subjects with Sensorineural Hearing Loss Associated with Speech-in-Noise Impairment

We are studying this investigational drug to find out if PIPE-505 is safe and tolerated, any effects PIPE-505 has to human health, how much PIPE-505 is absorbed by the body, and any impact on PIPE-505 has on hearing.

  • 226 views
  • 30 Jul, 2020
  • 1 location
featured
ValEAR

To determine if treatment of cCMV-infected hearing impaired infants with isolated hearing loss with the antiviral drug valganciclovir reduces the maximum worsening in left or right ear hearing 8

  • 144 views
  • 11 Jun, 2020
  • 1 location
featured
SHINE Study: We're looking for young adults to volunteer a clinical research study exploring new immunization options for meningococcal diseases like meningitis.

SHINE Study: We're looking for young adults to volunteer a clinical research study exploring new immunization options for meningococcal diseases like meningitis.

  • 350 views
  • 08 Nov, 2020
  • 1 location
featured
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

  • 142 views
  • 08 Dec, 2020
  • 1 location
Hearing for Communication and Resident Engagement

Amplification is a well-established, evidence-based front-line treatment for those with impaired communication secondary to Age Related Hearing Loss (ARHL). ARHL is the most prevalent cause of

  • 0 views
  • 13 Jun, 2021
  • 1 location
Early Communication Intervention for Toddlers With Hearing Loss

Improving spoken language outcomes for children with hearing loss has important public health implications. This is a randomized clinical trial of 96 children with hearing loss that examines the

  • 3 views
  • 09 Mar, 2021
  • 1 location
Hearing Loss and Communication Needs in a Group Care Setting for Older Adults

The purpose of this study is to develop and test a multicomponent hearing care intervention for the PACE staff members in order to learn more about communication and engagement.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Hydrogen-oxygen Gas Mixture Inhalation in Patients With Sudden Sensorineural Hearing Loss

Idiopathic sudden sensorineural hearing loss (ISSHL) is defined according to American Academy of Otolaryngology as a hearing loss of at least 30 decibel over 3 contiguous test frequencies

  • 0 views
  • 16 May, 2021
  • 1 location
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation

Disequilibrium between acid and base in the inner ear was suggested to be an important factor leading to hearing impairment associated with SLC26A4 mutations. For acid-base homeostasis in

hearing impairment
  • 83 views
  • 07 Nov, 2020
Relationship Between Auto NRT and Behavioural T & C Levels With the Nucleus Freedom Cochlear Implant

Cochlear implants require programming on an individual basis to provide appropriate levels of electrical stimulation. This program, or "map", is placed in the speech processor of the cochlear implant. Success of implantation largely depends on the adequacy of this map. Cochlear implant fitting remains a difficult challenge in congenitally or …

electrical stimulation
cochlear implant
seizure
  • 30 views
  • 07 Nov, 2020
  • 1 location